APUS · Apimeds Pharmaceuticals US, Inc. · Analyst Estimates
$1.85
+0.18 (+10.48%)
At close · Sep 18
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.47M
Shares
1.51M
Analyst Estimates
Compare analyst forecasts for Apimeds Pharmaceuticals US, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
This verified capture contains no analyst forecast observations. Older snapshots remain in the history.
Captured 2026-09-18 08:34 UTC · Publication dates shown per estimate · 0 metric / period groups